Red Cross Says J&J's Anti-Bleeding Patches Infringe Patents

Law360, New York (April 19, 2013, 4:52 PM EDT) -- Johnson & Johnson and two of its subsidiaries were hit with a suit in Texas federal court Tuesday by the American Red Cross and a biotechnology company that licenses two of its patents, saying J&J's anti-bleeding sealant patches infringe them.

According to the suit, sealant patches made by Israel-based J&J unit Omrix Biopharmaceuticals Ltd. and distributed in the U.S. by Ethicon Inc., another J&J unit, infringe two patents — U.S. Patent Numbers 7,189,410 and 7,196,054, both titled “Supplemented and Unsupplemented Tissue Sealants, Methods of Their Production and...
To view the full article, register now.